Medicenna Therapeutics Corp at Oppenheimer Healthcare Conference (Virtual) Transcript
Hey, good afternoon, everyone. Thanks for joining the Annual Healthcare Conference. My name is Matt Biegler. I'm a covering analyst here. Pleased to be joined by one of my covered companies, which is Medicenna. We're with CEO, Fahar Merchant. Fahar, welcome.
Thank you, and thank you, Matt, for inviting us to participate in your conference today.
Questions & Answers
We are going to be doing a fireside chat for those interested. So maybe I'll just start with the high level question. I think a lot of people think of medicine as kind of a one trick pony in the IL-2 space, with a modified IL-2 agonist, which is MDNA11. We'll obviously talk a lot about -- a lot of it I've heard about that today. But there's much more to Medicenna, I guess, that you guys have under the hood. So maybe if you can just walk us through the story and what you guys are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
